These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 19824815)

  • 1. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease.
    Whitsett JA; Wert SE; Weaver TE
    Annu Rev Med; 2010; 61():105-19. PubMed ID: 19824815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar injury and regeneration following deletion of ABCA3.
    Rindler TN; Stockman CA; Filuta AL; Brown KM; Snowball JM; Zhou W; Veldhuizen R; Zink EM; Dautel SE; Clair G; Ansong C; Xu Y; Bridges JP; Whitsett JA
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar lipids in pulmonary disease. A review.
    Agudelo CW; Samaha G; Garcia-Arcos I
    Lipids Health Dis; 2020 Jun; 19(1):122. PubMed ID: 32493486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.
    Citti A; Peca D; Petrini S; Cutrera R; Biban P; Haass C; Boldrini R; Danhaive O
    Ultrastruct Pathol; 2013 Oct; 37(5):356-65. PubMed ID: 24047351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered surfactant homeostasis and recurrent respiratory failure secondary to TTF-1 nuclear targeting defect.
    Peca D; Petrini S; Tzialla C; Boldrini R; Morini F; Stronati M; Carnielli VP; Cogo PE; Danhaive O
    Respir Res; 2011 Aug; 12(1):115. PubMed ID: 21867529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease.
    Mulugeta S; Nureki S; Beers MF
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L507-25. PubMed ID: 26186947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diseases of pulmonary surfactant homeostasis.
    Whitsett JA; Wert SE; Weaver TE
    Annu Rev Pathol; 2015; 10():371-93. PubMed ID: 25621661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pulmonary expression of granulocyte-macrophage colony-stimulating factor and surfactant protein in adult idiopathic pulmonary alveolar proteinosis].
    Zhou XM; Bai JW; Cai HR; Wu HY; Chen J
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):832-5. PubMed ID: 16316563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between pulmonary surfactant and alveolar macrophages in the pathogenesis of lung disease.
    Yoshida M; Whitsett JA
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL639-48. PubMed ID: 15579257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung diseases in children associated with inherited disorders of surfactant metabolism].
    Delestrain C; Flamein F; Jonard L; Couderc R; Guillot L; Fanen P; Epaud R
    Rev Pneumol Clin; 2013 Aug; 69(4):183-9. PubMed ID: 23856024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice.
    Besnard V; Matsuzaki Y; Clark J; Xu Y; Wert SE; Ikegami M; Stahlman MT; Weaver TE; Hunt AN; Postle AD; Whitsett JA
    Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L646-59. PubMed ID: 20190032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.
    Pang Q; Liu C; Qiao Y; Zhao J; Lam SM; Mei M; Shui G; Bao S; Li Q
    Sci China Life Sci; 2022 Jan; 65(1):193-205. PubMed ID: 33740186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin beta6 mediates phospholipid and collectin homeostasis by activation of latent TGF-beta1.
    Koth LL; Alex B; Hawgood S; Nead MA; Sheppard D; Erle DJ; Morris DG
    Am J Respir Cell Mol Biol; 2007 Dec; 37(6):651-9. PubMed ID: 17641300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction.
    Cooney AL; Wambach JA; Sinn PL; McCray PB
    Front Genome Ed; 2021; 3():785829. PubMed ID: 35098209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
    Reed JA; Whitsett JA
    Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic disorders of surfactant dysfunction.
    Wert SE; Whitsett JA; Nogee LM
    Pediatr Dev Pathol; 2009; 12(4):253-74. PubMed ID: 19220077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.
    Douda DN; Farmakovski N; Dell S; Grasemann H; Palaniyar N
    Orphanet J Rare Dis; 2009 Dec; 4():29. PubMed ID: 20030831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Alveolar Proteinosis Syndrome.
    Suzuki T; Trapnell BC
    Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell.
    Sitaraman S; Alysandratos KD; Wambach JA; Limberis MP
    Hum Gene Ther; 2022 Oct; 33(19-20):1011-1022. PubMed ID: 36166236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18:1/18:1-Dioleoyl-phosphatidylglycerol prevents alveolar epithelial apoptosis and profibrotic stimulus in a neonatal piglet model of acute respiratory distress syndrome.
    Preuß S; Scheiermann J; Stadelmann S; Omam FD; Winoto-Morbach S; Lex D; von Bismarck P; Adam-Klages S; Knerlich-Lukoschus F; Wesch D; Held-Feindt J; Uhlig S; Schütze S; Krause MF
    Pulm Pharmacol Ther; 2014 Jun; 28(1):25-34. PubMed ID: 24140177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.